𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results

✍ Scribed by M. LAZZERINI; S. MARTELOSSI; F. MARCHETTI; A. SCABAR; F. BRADASCHIA; L. RONFANI; A. VENTURA


Book ID
108604847
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
559 KB
Volume
25
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Immunogenicity and safety of influenza v
✍ Jennifer C.C. deBruyn; Robert Hilsden; Kevin Fonseca; Margaret L. Russell; Gilaa πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

Background: Protection against vaccine-preventable diseases is important in inflammatory bowel disease (IBD) because of increased susceptibility and severity of infection with immunosuppressive therapy. However, immunosuppressive therapy may affect vaccine response. This study aimed to evaluate immu

Prevalence and management of anemia in c
✍ James R. Goodhand; Nikolasos Kamperidis; Arati Rao; Faiden Laskaratos; Adam McDe πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 819 KB

Background: Children and adolescents with inflammatory bowel disease (IBD) are more likely to have Crohn's disease (CD) than ulcerative colitis (UC) and their disease tends to be more extensive and severe than in adults. We hypothesized that the prevalence of anemia would therefore be greater in chi

Long-term safety and efficacy of etanerc
✍ Daniel J. Lovell; Andreas Reiff; Olcay Y. Jones; Rayfel Schneider; James Nocton; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticular‐course juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye